Slava Therapeutics Private Limited

Develops and sells pharmaceutical products for cancer, dialysis, and infertility treatments.

2017 | Hyderabad, Telangana (India) | Active
Last Updated:

Slava Therapeutics Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 7 Months
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 5.23 Cr
  • Revenue Growth 137.51%
  • Profit Growth 163.11%
  • Ebitda 165.80%
  • Net Worth 184.33%
  • Total Assets 329.31%

About Slava Therapeutics

Slava Therapeutics Private Limited (STPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 July 2017 (Seven years and seven months 26 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹5.23 Cr.

Mohana Gopinath and Sirisha Pilla serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    slavatherapeutics.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24304TG2017PTC118116

  • Company No.

    118116

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    06 Jul 2017

  • Date of AGM

    31 Dec 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Slava Therapeutics?

Board Members (2)

NameDesignationAppointment DateStatus
Mohana Gopinath Country flag representing In Director 13-Nov-2020Current
Sirisha Pilla Country flag representing In Director 06-Jul-2017Current

Financial Performance of Slava Therapeutics.

Slava Therapeutics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 137.51% increase. The company also saw a substantial improvement in profitability, with a 163.11% increase in profit. The company's net worth Soared by an impressive increase of 184.33%.

Slava Therapeutics revenue growth over time
Slava Therapeutics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
137.51%
Revenue from Operations
137.64%
Total Assets
329.31%
Profit or Loss
163.11%
Net Worth
184.33%
EBITDA
165.80%

What is the Ownership and Shareholding Structure of Slava Therapeutics?

In 2020, Slava Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹52.25 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 4.90 Cr
  • Hdfc Bank Limited : 0.33 Cr

Latest Charge Details

DateLenderAmountStatus
21 Nov 2020Hdfc Bank Limited₹3.25 MOpen
21 Mar 2020Others₹4.90 CrOpen

How Many Employees Work at Slava Therapeutics?

Unlock and access historical data on people associated with Slava Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Slava Therapeutics Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Slava Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Slava Therapeutics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Slava Therapeutics

Recent activity within the organization

  • Charges

    A charge with Others of Rs. 49.00 M registered on 21 Mar 2020 with Charge ID 100333848 was modified on 28 Feb 2024.

  • Annual General Meeting

    Slava Therapeutics Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 3.25 M with Charge ID 100417438 was registered on 21 Nov 2020.

  • Director Appointment

    Mohana Krishna Gopinath was appointed as a Director was appointed as a Director on 13 Nov 2020 & has been associated with this company since 4 years 3 months .

  • Balance Sheet

    Slava Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.

  • Charges

    A charge with Others amounted to Rs. 49.00 M with Charge ID 100333848 was registered on 21 Mar 2020.

Frequently asked questions

  • What is the Incorporation or founding date of Slava Therapeutics Private Limited?

    Slava Therapeutics Private Limited was incorporated on 06 Jul 2017.

  • What is authorized share capital and paid-up capital of Slava Therapeutics Private Limited?

    The authorized share capital of Slava Therapeutics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Slava Therapeutics Private Limited?

    Currently 2 directors are associated with Slava Therapeutics Private Limited.

    • Mohana Krishna Gopinath
    • Sirisha Pilla

  • What is the registered address of Slava Therapeutics Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Slava Therapeutics Private Limited is D No 15-29-1000/Hig-129 Room 3B Third Floor Pramani Plaza Phase1 2 Kphb Colony, Kukat Pally India, Hyderabad, Telangana, 500085.

  • What is the corporate identification number (CIN) and company number of Slava Therapeutics Private Limited?

    The corporate identification number (CIN) of Slava Therapeutics Private Limited is U24304TG2017PTC118116 and the company number is 118116 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Slava Therapeutics Private Limited?

    The Official website of Slava Therapeutics Private Limited is https://www.slavatherapeutics.com

  • What has been the recent revenue trend for Slava Therapeutics Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Slava Therapeutics Private Limited has risen by 137.51%.

  • What change has been observed in the net worth of Slava Therapeutics Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Slava Therapeutics Private Limited has experienced an upsurge of 184.33%.

  • What are the total open charges for Slava Therapeutics Private Limited?

    As per the financial statements for fiscal Year 2020, The total open charges for Slava Therapeutics Private Limited amount to ₹ 5.23 Cr.

  • When was the last Balance Sheet of Slava Therapeutics Private Limited filed with the ROC?

    The most recent Balance Sheet for Slava Therapeutics Private Limited was filed with the ROC on 31 Mar 2020.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors